Zenith Healthcare share price, mcap and merger note 2026

Overview

Zenith Healthcare Limited (ZENITHHE) is an integrated pharmaceutical company in India that manufactures pharmaceutical formulations and offers contract manufacturing across multiple therapeutic areas. Market participants often track small-cap pharma names like Zenith Healthcare for corporate action updates, regulatory filings, and business footprint. As per the provided data, the stock and company snapshot is available for 7 July 2026, along with older corporate action information linked to a proposed amalgamation.

This note summarises the reported share price and market capitalisation, the company’s core business description, its listed symbol on the exchange, and the key addresses and contact points shared. It also recaps the amalgamation-related board meeting disclosure from 2018 and highlights what is explicitly stated about tracking mergers and demergers on Pocketful.

Stock snapshot as of 7 July 2026

The share price of ZENITHHE is stated as ₹3.18 as on 7 July 2026. The market capitalisation of Zenith Healthcare Ltd (ZENITHHE) is stated as ₹16.39 crore as of the same date. These two data points help frame the company’s size in the listed market and indicate that it sits in the micro-cap bracket by market value.

Because the provided information does not include trading volume, 52-week range, or recent price performance, the snapshot is limited to the point-in-time price and market cap. Any inference about momentum or trend would require additional market data not present here. Investors typically use such a snapshot as a starting point and then refer to filings, corporate actions, and business updates to understand what may be influencing the stock.

What Zenith Healthcare does

Zenith Healthcare Limited is described as an integrated pharmaceutical company in India. It manufactures various pharmaceutical formulations and offers contract manufacturing services across multiple therapeutic areas. This positioning places the company in a segment where operational execution, compliance, and customer relationships can matter as much as product mix.

The provided data does not specify product categories, regulated market exposure, or customer concentration. It also does not include revenue, profitability, capacity, or order book details. As a result, this article focuses on the factual identifiers and corporate action references that are explicitly included.

Exchange identification and company reference details

The BSE symbol provided for the company is 530665. This is a key identifier for investors who track the company on BSE disclosures and market data feeds. The material also references the company website as http://www.zenithhealthcare.com.

A table in the source content indicates the parent organisation as Zenith Healthcare Limited, which aligns with the company name used across the addresses and contact sections.

Registered and corporate office details

The registered and corporate office information in the provided content lists an Ahmedabad address and multiple email IDs and phone numbers. The corporate office is stated as:

• 504, Iscon Elegance, Nr. Shapath 5, S.G. Road, Ahmedabad-380015

Emails mentioned include:

• info@zenithhealthcare.com
• mahendrazenith@hotmail.com (listed more than once in the source text)

Phone numbers mentioned include:

• (079) 66168889, (079) 66168890

Mobile numbers mentioned include:

• +91 98250 97076, +91 94265 16103

The repetition of one email in the source is retained here as an observation rather than interpreted.

Manufacturing site (works) and operational footprint

The works location is stated as:

• 388/34, Changodar Industrial Estate, Sarkhej-Bawla Highway, Changodar-382 213, Dist. Ahmedabad

Contact details for the works site include:

• Phone: (02717) 250048, (02717) 250593
• Fax: (02717) 251262

A second listing of the work section includes:

• Mobile: +91 9979503977

The text also includes additional addresses such as a Changodar location near Hotel Orion and a Kolkata address at Ground Floor, Kanak Villa, E/94/1, Nr. Ramkishan Asharam, Baghajatin, Kolkata, West Bengal 700086. Since the content does not specify whether these are offices, depots, or other facilities, they are presented as locations referenced in the provided material.

Agent information mentioned in the disclosure

The source content includes an “Agent Information” section with a Mumbai address:

• 1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri (East), Mumbai 400059, Maharashtra

Contact lines include:

• Board No: 022 62638200
• Fax No: 022 62638299

The Mumbai address appears twice in the provided text. No further context is provided on the scope of the agent’s responsibilities.

Amalgamation proposal: what is explicitly stated

The provided content refers to an “Application malgamation” involving Zenith Healthcare Limited (ZHL) as the transferee company and Zenith Medicine Pvt. Ltd. (ZMPL) as the transferor company. It also includes a specific BSE intimation describing a board meeting.

According to the disclosure cited, ZENITH HEALTH CARE LTD informed BSE that a meeting of the Board of Directors was scheduled on 19/10/2018. The agenda mentioned includes considering and approving the notice of the company’s 4th Board Meeting (04/2018-19) to be held on 19.10.2018, including consideration of the proposal for the amalgamation.

The text also references an “Approval Date” field, described as the date on which shareholders and regulatory authorities approve the proposed restructuring. However, no actual approval date is provided in the supplied material.

Tracking mergers and demergers on Pocketful

The content includes a short set of steps titled “To track mergers and demergers of Zenith Health Care Ltd on Pocketful”. It instructs users to:

• Visit the Zenith Health Care Ltd stock page on the Pocketful platform
• Navigate to the Corporate Actions section
• Select the Mergers and Demergers tab to view announced, ongoing, or completed restructuring activities

The same source also shows a timestamp reference: Sat, 09 May 2026, 04:04 pm, without additional context on what update occurred at that time.

Key facts table (from the provided data)

Market impact and context (limited to available facts)

From the information given, the immediate market context is limited to the stock’s price level and market capitalisation as of 7 July 2026. The presence of a historical amalgamation proposal reference highlights why corporate action tracking can matter for smaller listed companies, where restructuring events can be material for shareholders.

However, the provided content does not include the outcome of the 2018 board process, regulatory responses, shareholder voting results, or implementation details. Without those specifics, it is not possible to quantify the effect of the proposed amalgamation on financials, shareholding, or operations based solely on this input.

Conclusion

Zenith Healthcare Ltd (ZENITHHE) was reported at ₹3.18 per share with a ₹16.39 crore market cap as of 7 July 2026, and is identified on BSE under symbol 530665. The company is described as an integrated pharma manufacturer and contract manufacturer, with listed office and works addresses in Ahmedabad and an agent address in Mumbai.

For corporate actions, the provided record points to a board meeting scheduled on 19 October 2018 to consider an amalgamation proposal involving Zenith Medicine Pvt. Ltd. Tracking tools like the Pocketful Corporate Actions section are explicitly suggested in the source for following such restructuring items when they are announced, ongoing, or completed.